Coverage
-
January 19, 2024
The pharmaceutical industry lost another round in court in recent days amid a forceful push to narrow enforcement of the Anti-Kickback Statute, leaving the status quo in place for now but generating uncertainty over what's next, experts say.
12 other articles on this case.
View all »